EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SOD1 Protein Content in Human Central Nervous System and Peripheral Tissues

Laura Leykam iD, P Andreas Jonsson iD, Karin M E Forsberg iD, Peter M Andersen iD, Thomas Brännström iD, Stefan L Marklund iD, Per Zetterström iD

Journal of Neurochemistry · 2025-06 · 169 (6)

DOI: 10.1111/jnc.70136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, online erschienen am 23.06.2025. Verfasst von Laura Leykam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Superoxide Dismutase-1, Central Nervous System, Superoxide Dismutase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Olsson och Olsson Välgörenhetsstiftelse, King Gustaf V:s and Queen Victoria's Freemason's Foundation, Fort Knox Välgörenhetsstiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene silencing therapy is an effective treatment for amyotrophic lateral sclerosis (ALS) patients carrying mutations in the superoxide dismutase‐1 ( SOD1 ) gene aiming to reduce noxious forms of SOD1 in the central nervous system (CNS). The normal steady‐state level of SOD1 protein in human CNS is therefore of interest but is contested. In this work we have analyzed SOD1 protein content, total protein content, and SOD1 enzymatic activity in six areas of the CNS as well as in four peripheral tissues from sporadic and familial ALS patients and non‐ALS controls. Our results show that SOD1 in the human CNS constitutes around 100 μg/g wet weight corresponding to about 0.16% of the total protein in the studied areas. Of the peripheral tissues analyzed, kidney and erythrocytes contain roughly equal amounts, liver higher, and skeletal muscle lower levels of SOD1 compared to the CNS. This data shows SOD1 protein levels around 10 times lower compared to previously published figures. However, SOD1 can still be considered an abundant protein considering that > 12 000 proteins are expressed in human cells. There was no difference in SOD1 protein content between sporadic or familial ALS patients and control individuals. The level and activity of SOD1 are not deviating in the areas of the CNS that are most vulnerable to ALS. Instead, insufficient control of SOD1 structure and aggregation could be important factors behind the vulnerability of motor areas to SOD1 proteotoxicity. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Superoxide Dismutase-1Central Nervous SystemSuperoxide DismutaseHumansAmyotrophic Lateral SclerosisMaleFemaleMiddle AgedAgedAdultMuscle, Skeletal

Stichwörter der Autor:innen

ALSSOD1SOD1 protein contentamyotrophic lateral sclerosis

Substanzen

Superoxide Dismutase-1SOD1 protein, humanSuperoxide Dismutase

Autor:innen und Institutionen

  • Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.
  • Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Department of Clinical Sciences, Neurosciences, Umeå University, Umeå, Sweden.
  • Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.

ORCID-Profile: Laura Leykam, P Andreas Jonsson, Karin M E Forsberg, Peter M Andersen, Thomas Brännström, Stefan L Marklund, Per Zetterström

Förderung

  • Olsson och Olsson Välgörenhetsstiftelse
  • King Gustaf V:s and Queen Victoria's Freemason's Foundation
  • Fort Knox Välgörenhetsstiftelse
  • Umeå University Insamlingsstiftelsen
  • Västerbotten Läns Landsting
  • Ulla-Carin Lindquists stiftelse för ALS-forskning
  • Neuroförbundet
  • Vetenskapsrådet

Zitieren

APA

Leykam, L., Jonsson, P. A., Forsberg, K. M. E., Andersen, P. M., Brännström, T., Marklund, S. L., & Zetterström, P. (2025). SOD1 Protein Content in Human Central Nervous System and Peripheral Tissues. Journal of Neurochemistry, 169(6). https://doi.org/10.1111/jnc.70136

Vancouver

Leykam L, Jonsson PA, Forsberg KME, Andersen PM, Brännström T, Marklund SL, et al. SOD1 Protein Content in Human Central Nervous System and Peripheral Tissues. Journal of Neurochemistry. 2025;169(6). doi:10.1111/jnc.70136

BibTeX
@article{Leykam2025,
  author = {Leykam, Laura and Jonsson, P Andreas and Forsberg, Karin M E and Andersen, Peter M and Brännström, Thomas and Marklund, Stefan L and Zetterström, Per},
  title = {SOD1 Protein Content in Human Central Nervous System and Peripheral Tissues},
  journal = {Journal of Neurochemistry},
  year = {2025},
  volume = {169},
  number = {6},
  doi = {10.1111/jnc.70136}
}
Kostenlos starten →